{"text": ["Incyte", "(INCY)", "Q4", "Earnings", "Miss", "Estimates,", "Revenues", "Beat"], "created_at": "2019-02-14 20:38:09"}
{"text": ["Incyte", "(INCY)", "Q4", "Earnings", "Miss", "Estimates,", "Revenues", "Beat"], "created_at": "2019-02-14 20:38:09"}
{"text": ["Incyte", "(INCY)", "Q4", "Earnings", "Miss", "Estimates,", "Revenues", "Beat"], "created_at": "2019-02-14 18:49:06"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "ExxonMobil,", "Merck,", "Danaher,", "Novartis", "and", "Expedia"], "created_at": "2019-02-14 17:37:37"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "ExxonMobil,", "Merck,", "Danaher,", "Novartis", "and", "Expedia"], "created_at": "2019-02-14 17:37:37"}
{"text": ["The", "Zacks", "Analyst", "Blog", "Highlights:", "ExxonMobil,", "Merck,", "Danaher,", "Novartis", "and", "Expedia"], "created_at": "2019-02-14 15:50:03"}
{"text": ["The", "Daily", "Biotech", "Pulse:", "Vanda", "Q4", "Results,", "Inovio", "Debt", "Offering,", "Caladrius", "Diabetes", "Drug", "Flunks", "Mid-Stage", "Trial"], "created_at": "2019-02-14 12:50:18"}
{"text": ["[$$]", "J&J", "and", "Novartis", "back", "cancer", "geneticist\u2019s", "immunotherapy", "start-up"], "created_at": "2019-02-14 05:53:01"}
